Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02133742
Title A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

renal cell carcinoma

Therapies

Axitinib + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.